Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

11.99
Delayed Data
As of May 27
 -0.28 / -2.28%
Today’s Change
10.61
Today|||52-Week Range
36.38
-27.51%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close12.27
Today’s open12.35
Day’s range11.85 - 12.62
Volume307,126
Average volume (3 months)280,315
Market cap$307.5M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-25.40%
Earnings growth (this year)+1.71%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+68.18%
P/E ratio--
Price/Sales34.95
Price/Book2.32

Competitors

 Today’s
change
Today’s
% change
RXDXIgnyta Inc+0.14+2.10%
AGENAgenus Inc+0.15+3.85%
VYGRVoyager Therapeutics...+0.88+6.89%
BTXBioTime Inc+0.11+3.97%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateJune 3, 2016
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$10.5M
Annual profit (last year)-$79.3M
Net profit margin-758.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Don Soland
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts

Partner Offers

Search for Jobs